NDC 13533-705-32 - Prolastin-C Liquid
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13533-705
- Requested NDC
- 13533-705-32
- Package NDCs from labels
- 13533-705-11, 13533-705-01, 13533-705-32, 13533-705-31, 13533-705-52, 13533-705-51
- Manufacturer
- GRIFOLS USA, LLC | Grifols Therapeutics LLC | Instituto Grifols SA | GRIFOLS WORLDWIDE OPERATIONS LIMITED | Grifols Biologicals LLC
- Effective date
- 2026-11-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Prolastin-C Liquid | GRIFOLS USA, LLC | Grifols Therapeutics LLC | Instituto Grifols SA | GRIFOLS WORLDWIDE OPERATIONS LIMITED | Grifols Biologicals LLC | 2026-11-01 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 13533-705-01 | Prolastin-C Liquid | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 14 | |
| 13533-705-11 | Prolastin-C Liquid | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 14 | |
| 13533-705-31 | Prolastin-C Liquid | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 14 | |
| 13533-705-32 | Prolastin-C Liquid | 10 mL in 1 VIAL | INJECTION, SOLUTION | 10 | 14 | |
| 13533-705-51 | Prolastin-C Liquid | 1 in 1 CARTON | INJECTION, SOLUTION | 1 | 14 | |
| 13533-705-52 | Prolastin-C Liquid | 80 mL in 1 VIAL | INJECTION, SOLUTION | 80 | 14 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 13533-705-01 | EA - Each | 13533-705 | c405c690-672b-4ea6-9ae2-a0f401deddbe | 1 | 2018-02-20 |
| 13533-705-11 | EA - Each | 13533-705 | 8123ca96-5a33-443f-8070-53f5900ccf6f | 1 | 2018-02-20 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| INSULIN DILUTING MEDIUM FOR Kirsty | WATER | Biocon Biologics Inc. | 3db1d482-7e1f-aec6-79ef-3f305b4d8277 | 2026-01-20 | Warnings, Adverse reactions | 059QF0KO0R |
| E.O.L. | STILLINGIA SYLVATICA, ZINCUM GLUCONICUM, THIAMINUM HYDROCHLORICUM, FRAGARIA VESCA, NICOTINAMIDUM, RHEUM (PALMATUM), SEROTONIN (HYDROCHLORIDE), 5-HYDROXYTRYPTOPHAN, BETAINUM MURIATICUM, BIOTIN, CHOLINUM, CYSTEINUM, DL-METHIONINE, L-ALANINE, L-CYSTINE, L-GLUTAMIC ACID, L-GLUTAMINE, L-LYSINE, L-METHIONINE, L-SERINE, PARA-AMINOBENZOIC ACID, POTASSIUM GLUCONATE, THYMUS (SUIS), THYROIDINUM (SUIS), UBIDECARENONUM, VITAMIN D3, DOPAMINE HYDROCHLORIDE, LITHIUM BROMATUM, SQUALENE, VACCINIUM MACROCARPON, OXYTOCIN, | InLight Creation, LLC. | b317d812-d6ed-4a2f-93f7-08b12261cc99 | 2026-01-09 | Warnings | OF5P57N2ZX |
| Plus Rinse Emergency Eyewash | PURIFIED WATER | INNOVATIVE SAFETY SUPPLY INC. | b3f47d26-39e4-4aea-bb92-358def52b652 | 2026-01-08 | Warnings | 059QF0KO0R |
| pH Neutral Emergency Eyewash | WATER | INNOVATIVE SAFETY SUPPLY INC. | 29a1bd1e-d0dd-478f-e063-6394a90ab0aa | 2026-01-08 | Warnings | 059QF0KO0R |
| Eye Clean | EYE WASH | HART Health | 41f53e2e-c2bc-4bf1-a541-3bcb2cf63002 | 2025-12-31 | Warnings | 059QF0KO0R |
| teeth and gums | CALC FLUORICA, CALC PHOS, FERRUM PHOS, KALI PHOS, MAG PHOS, MALUS PUMILA, FLOS, ROCK WATER, ULEX EUROPAEUS, FLOS | Siddha Flower Essences LLC | 926c79d5-d270-4c0d-aca9-b58571c24f3a | 2025-12-31 | Warnings | 059QF0KO0R |
| lung and sinus | CALC PHOS, FERRUM PHOS, GENTIANELLA AMARELLA, FLOS, KALI MUR, KALI PHOS, KALI SULPH, ROCK WATER, ROSE CANINA, FLOS | Siddha Flower Essences LLC | 9f7c949f-21bc-473c-ab8d-24837893fccc | 2025-12-31 | Warnings | 059QF0KO0R |
| Quality Choice Eye Wash | WATER | Chain Drug Marketing Assoc., Inc. | 1fb8a109-351b-7039-e063-6394a90a7311 | 2025-12-30 | Warnings | 059QF0KO0R |
| Rite Aid Eye Wash | PURIFIED WATER | Rite Aid | 28a18e04-d735-a511-e063-6394a90af6bb | 2025-12-30 | Warnings | 059QF0KO0R |
| OCUFRESH | WATER | Optics Laboratory Inc. | b8e477a9-66b9-496b-92fb-3d4bbd7b36b5 | 2025-12-29 | Warnings | 059QF0KO0R |
| Kollourion Eyesalve Eyewash | PURIFIED WATER 98.3% | Miracle Eye Pharmaceuticals | b56d2ab9-169b-b490-e053-2a95a90a80b3 | 2025-12-28 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | ProPharma Distribution | 386a0a2f-4ff7-f128-e063-6294a90a7d4d | 2025-12-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Firstep Firstflush | EYEWASH | Encon Safety Products, Inc. | a44beb26-79ae-98bd-e053-2995a90a9b74 | 2025-12-09 | Warnings | 059QF0KO0R |
| GLASSIA | ALPHA.1-PROTEINASE INHIBITOR HUMAN | Takeda Pharmaceuticals America, Inc. | 83473cbb-48e4-42a2-81b6-4c851423da7b | 2025-12-02 | Warnings, Adverse reactions | 1661208 F43I396OIS |
| Aralast NP | ALPHA-1-PROTEINASE INHIBITOR (HUMAN) | Takeda Pharmaceuticals America, Inc. | a9a5b46e-04da-41bd-bb5f-c4936b664fef | 2025-11-25 | Warnings, Adverse reactions | 1661208 |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.